1. |
Lin SM, Lin CJ, Lin CC, et al. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less [J]. Gut, 2005; 54(10)∶1508.
|
2. |
Tateishi R, Shiina S, Teratani T, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1 000 cases [J]. Cancer, 2005; 103(6)∶1201.
|
3. |
Vivarelli M, Guglielmi A, Ruzzenente A, et al. Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver [J]. Ann Surg, 2004; 240(1)∶102.
|
4. |
Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma [J]. Ann Surg, 2006; 243(3)∶321.
|
5. |
Lu MD, Xu HX, Xie XY, et al. Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study [J]. J Gastroenterol, 2005; 40(11)∶1054.
|
6. |
Mulier S, Ni Y, Jamart J, et al. Local recurrence after hepatic radiofrequency coagulation: multivariate metaanalysis and review of contributing factors [J]. Ann Surg, 2005; 242(2)∶158.
|
7. |
Cho YK, Rhim H, Ahn YS, et al. Percutaneous radiofrequency ablation therapy of hepatocellular carcinoma using multitined expandable electrodes: comparison of subcapsular and nonsubcapsular tumors [J]. AJR Am J Roentgenol, 2006; 186(5 Suppl)∶S269.
|
8. |
Teratani T, Yoshida H, Shiina S, et al. Radiofrequency ablation for hepatocellular carcinoma in socalled highrisk locations [J]. Hepatology, 2006; 43(5)∶1101.
|
9. |
Kim YK, Kim CS, Chung GH, et al. Radiofrequency ablation of hepatocellular carcinoma in patients with decompensated cirrhosis: evaluation of therapeutic efficacy and safety [J]. AJR Am J Roentgenol, 2006; 186(5 Suppl)∶S261.
|
10. |
Kim YS, Rhim H, Cho OK, et al. Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors [J]. Eur J Radiol, 2006; 59(3)∶432.
|
11. |
Raut CP, Izzo F, Marra P, et al. Significant longterm survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis [J]. Ann Surg Oncol, 2005; 12(8)∶579.
|
12. |
Kurokohchi K, Masaki T, Watanabe S, et al. Timelag performance of radiofrequency ablation after percutaneous ethanol injection for the treatment of hepatocellular carcinoma [J]. Int J Oncol, 2006; 28(4)∶971.
|
13. |
Lee JM, Kim YK, Lee YH, et al. Percutaneous radiofrequency thermal ablation with hypertonic saline injection: in vivo study in a rabbit liver model [J]. Korean J Radiol, 2003; 4(1)∶27.
|
14. |
Hansler J, Frieser M, Schaber S, et al. Radiofrequency ablation of hepatocellular carcinoma with a saline solution perfusion device: a pilot study [J]. J Vasc Interv Radiol, 2003; 14(5)∶575.
|
15. |
von Breitenbuch P, Kohl G, Guba M, et al. Thermoablation of colorectal liver metastases promotes proliferation of residual intrahepatic neoplastic cells [J]. Surgery, 2005; 138(5)∶882.
|
16. |
Vallone P, Catalano O, Izzo F, et al. Combined ethanol injection therapy and radiofrequency ablation therapy in percutaneous treatment of hepatocellular carcinoma larger than 4 cm [J]. Cardiovasc Intervent Radiol, 2006; 29(4)∶544.
|